531
Articles
24.8K
Citations
3.6
avg. Impact Factor
87
h-index

Most Cited Articles of Division of Hematology in 2004

TitleJournalYearCitations
Clinical course of patients with relapsed multiple myelomaMayo Clinic Proceedings2004266
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virusCancer Research2004237
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcomeBlood2004193
Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivoBlood2004148
Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years laterMayo Clinic Proceedings2004138
Imatinib targets other than bcr/abl and their clinical relevance in myeloid disordersBlood2004110
Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphomaMayo Clinic Proceedings200469
Thalidomide: tragic past and promising futureMayo Clinic Proceedings200468
Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasiaMayo Clinic Proceedings200457
Ethical issues in geriatrics: a guide for cliniciansMayo Clinic Proceedings200445
Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization fourier-transform ion-cyclotron-resonance mass spectrometryClinical Chemistry200442
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significanceBritish Journal of Haematology200440
Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatmentInternal Medicine200433
Advances in Screening, Diagnosis, and Treatment of Breast CancerMayo Clinic Proceedings200425
Yttrium-90-ibritumomab tiuxetan radioimmunotherapy: a new treatment approach for B-cell non-Hodgkin's lymphomaDrugs of Today200425
Current approach to diagnosis and management of chronic lymphocytic leukemiaMayo Clinic Proceedings200424
Therapeutic options in patients with lymphoma and severe liver dysfunctionMayo Clinic Proceedings200423
Primer on medical genomics. Part XIII: Ethical and regulatory issuesMayo Clinic Proceedings200422
Morbidity and mortality of deep sedation in outpatient bone marrow biopsyAmerican Journal of Hematology200419
Advances in screening, diagnosis, and treatment of breast cancerMayo Clinic Proceedings200418
Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanomaCytotherapy200417
Severe, reversible pulmonary hypertension in a patient with monoclonal gammopathy and features of dermatomyositisMayo Clinic Proceedings200417
Fatal coronary artery disease after unrelated donor bone marrow transplantationMayo Clinic Proceedings200413
G-CSF Administration Increases Pulmonary Toxicity for Hodgkin’s Disease Patients Treated with Bleomycin-Containing Chemotherapy.Blood20044
Anagrelide: an update on its mechanisms of action and therapeutic potentialExpert Review of Anticancer Therapy20043